

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 8.12006392 |
| 2 | oligosaccharide catabolic process (GO:0009313) | 6.40573324 |
| 3 | glycosphingolipid catabolic process (GO:0046479) | 6.22353038 |
| 4 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 5.81052436 |
| 5 | glycolipid catabolic process (GO:0019377) | 5.58878236 |
| 6 | amino sugar catabolic process (GO:0046348) | 5.33445504 |
| 7 | ceramide catabolic process (GO:0046514) | 4.97854303 |
| 8 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.72563561 |
| 9 | regulation of mononuclear cell migration (GO:0071675) | 4.68284416 |
| 10 | eosinophil chemotaxis (GO:0048245) | 4.62549527 |
| 11 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.57711423 |
| 12 | osteoclast differentiation (GO:0030316) | 4.54734900 |
| 13 | regulation of monocyte differentiation (GO:0045655) | 4.54478838 |
| 14 | negative regulation of interleukin-12 production (GO:0032695) | 4.53588002 |
| 15 | regulation of cholesterol storage (GO:0010885) | 4.52405512 |
| 16 | response to peptidoglycan (GO:0032494) | 4.27201157 |
| 17 | myeloid dendritic cell differentiation (GO:0043011) | 4.21960159 |
| 18 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.16677425 |
| 19 | eosinophil migration (GO:0072677) | 4.10406957 |
| 20 | monocyte chemotaxis (GO:0002548) | 4.00180041 |
| 21 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.96655144 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 3.92276603 |
| 23 | response to thyroid hormone (GO:0097066) | 3.91952097 |
| 24 | membrane lipid catabolic process (GO:0046466) | 3.88907420 |
| 25 | sphingolipid catabolic process (GO:0030149) | 3.85574112 |
| 26 | N-acetylneuraminate metabolic process (GO:0006054) | 3.84319980 |
| 27 | glucosamine-containing compound catabolic process (GO:1901072) | 3.83722586 |
| 28 | myeloid dendritic cell activation (GO:0001773) | 3.74856878 |
| 29 | positive regulation of bone remodeling (GO:0046852) | 3.68626305 |
| 30 | positive regulation of bone resorption (GO:0045780) | 3.68626305 |
| 31 | regulation of vitamin metabolic process (GO:0030656) | 3.59760910 |
| 32 | positive regulation of osteoclast differentiation (GO:0045672) | 3.57450682 |
| 33 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.49294101 |
| 34 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.46888630 |
| 35 | regulation of podosome assembly (GO:0071801) | 3.46637505 |
| 36 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.40940379 |
| 37 | decidualization (GO:0046697) | 3.36986538 |
| 38 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.33399551 |
| 39 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.22442554 |
| 40 | cellular extravasation (GO:0045123) | 3.18798193 |
| 41 | dendritic cell differentiation (GO:0097028) | 3.17947983 |
| 42 | NIK/NF-kappaB signaling (GO:0038061) | 3.17779885 |
| 43 | macrophage differentiation (GO:0030225) | 3.15629732 |
| 44 | macrophage activation involved in immune response (GO:0002281) | 3.10643232 |
| 45 | positive regulation of tissue remodeling (GO:0034105) | 3.10523199 |
| 46 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.10411046 |
| 47 | positive regulation of leukocyte degranulation (GO:0043302) | 3.08627553 |
| 48 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.08060082 |
| 49 | ganglioside metabolic process (GO:0001573) | 3.07493922 |
| 50 | cellular response to arsenic-containing substance (GO:0071243) | 3.06917608 |
| 51 | phagosome maturation (GO:0090382) | 3.06824627 |
| 52 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.05475520 |
| 53 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.05156997 |
| 54 | granulocyte activation (GO:0036230) | 3.04452979 |
| 55 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.01080965 |
| 56 | positive regulation of mast cell activation (GO:0033005) | 2.99798492 |
| 57 | immunoglobulin mediated immune response (GO:0016064) | 2.98825263 |
| 58 | negative regulation of lipid storage (GO:0010888) | 2.97814058 |
| 59 | positive regulation of heat generation (GO:0031652) | 2.96142994 |
| 60 | T-helper 1 type immune response (GO:0042088) | 2.95907181 |
| 61 | barbed-end actin filament capping (GO:0051016) | 2.95887735 |
| 62 | germinal center formation (GO:0002467) | 2.95612478 |
| 63 | regulation of mast cell degranulation (GO:0043304) | 2.91249199 |
| 64 | regulation of macrophage chemotaxis (GO:0010758) | 2.90242854 |
| 65 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.89586447 |
| 66 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.86444961 |
| 67 | cellular response to lipopolysaccharide (GO:0071222) | 2.84135098 |
| 68 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.80217651 |
| 69 | positive regulation of mast cell degranulation (GO:0043306) | 2.80217651 |
| 70 | regulation of fever generation (GO:0031620) | 2.78641198 |
| 71 | regulation of chronic inflammatory response (GO:0002676) | 2.78487223 |
| 72 | cellular response to molecule of bacterial origin (GO:0071219) | 2.75866835 |
| 73 | regulation of chemokine biosynthetic process (GO:0045073) | 2.73890785 |
| 74 | response to protozoan (GO:0001562) | 2.73643433 |
| 75 | regulation of lymphocyte migration (GO:2000401) | 2.73377044 |
| 76 | pinocytosis (GO:0006907) | 2.72121057 |
| 77 | keratan sulfate catabolic process (GO:0042340) | 2.71562344 |
| 78 | detection of molecule of bacterial origin (GO:0032490) | 2.70230219 |
| 79 | positive regulation of interleukin-6 production (GO:0032755) | 2.69444438 |
| 80 | regulation of superoxide anion generation (GO:0032928) | 2.68906216 |
| 81 | positive regulation of cholesterol efflux (GO:0010875) | 2.68656007 |
| 82 | protein localization to endosome (GO:0036010) | 2.68042165 |
| 83 | regulation of monocyte chemotaxis (GO:0090025) | 2.67955389 |
| 84 | vitamin D metabolic process (GO:0042359) | 2.66667109 |
| 85 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.66419394 |
| 86 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.64992582 |
| 87 | intracellular pH reduction (GO:0051452) | 2.63651134 |
| 88 | positive regulation of macrophage differentiation (GO:0045651) | 2.63218183 |
| 89 | positive regulation of lymphocyte migration (GO:2000403) | 2.63046252 |
| 90 | transferrin transport (GO:0033572) | 2.62872085 |
| 91 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.62377506 |
| 92 | regulation of mast cell activation (GO:0033003) | 2.61706102 |
| 93 | regulation of leukocyte degranulation (GO:0043300) | 2.61213917 |
| 94 | myeloid cell activation involved in immune response (GO:0002275) | 2.60639513 |
| 95 | apoptotic cell clearance (GO:0043277) | 2.59884331 |
| 96 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.59841782 |
| 97 | granulocyte chemotaxis (GO:0071621) | 2.58199649 |
| 98 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.57618834 |
| 99 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.57275447 |
| 100 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.56874826 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.89446475 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.78991713 |
| 3 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 4.66289244 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.19734516 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.89511777 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.61488107 |
| 7 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.49222042 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.41676875 |
| 9 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.13411345 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.98580577 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.86440073 |
| 12 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.37957559 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.34869776 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27387177 |
| 15 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.21707088 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.19097713 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.18327480 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.17839950 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.15978278 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.15850460 |
| 21 | SPI1_23127762_ChIP-Seq_K562_Human | 2.13480889 |
| 22 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.01986642 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.00631108 |
| 24 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.00058855 |
| 25 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.96690375 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.84477962 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.81256043 |
| 28 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.80114201 |
| 29 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.77586136 |
| 30 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77546253 |
| 31 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.72405129 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.72075692 |
| 33 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.68004327 |
| 34 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.67674677 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.65086917 |
| 36 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.65023897 |
| 37 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.64186075 |
| 38 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62014183 |
| 39 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.56860813 |
| 40 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.56485609 |
| 41 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.55971967 |
| 42 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.54493252 |
| 43 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.51392962 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50952844 |
| 45 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.47974212 |
| 46 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.45591737 |
| 47 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.43912386 |
| 48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.43623180 |
| 49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40826912 |
| 50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.34838574 |
| 51 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.34447749 |
| 52 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.33843930 |
| 53 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33824885 |
| 54 | MAF_26560356_Chip-Seq_TH1_Human | 1.33597273 |
| 55 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31267740 |
| 56 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28696148 |
| 57 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27851468 |
| 58 | GATA1_19941826_ChIP-Seq_K562_Human | 1.26852682 |
| 59 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25793657 |
| 60 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24590841 |
| 61 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.21812318 |
| 62 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.20057877 |
| 63 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16238617 |
| 64 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15959285 |
| 65 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15472263 |
| 66 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.13894274 |
| 67 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13605912 |
| 68 | MYB_26560356_Chip-Seq_TH2_Human | 1.10996797 |
| 69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10641548 |
| 70 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08989414 |
| 71 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07254598 |
| 72 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04008402 |
| 73 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03648504 |
| 74 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03213771 |
| 75 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.01370727 |
| 76 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98041328 |
| 77 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97480317 |
| 78 | UTX_26944678_Chip-Seq_JUKART_Human | 0.97373766 |
| 79 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97020179 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96875416 |
| 81 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96126375 |
| 82 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96071998 |
| 83 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.95966635 |
| 84 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.93827060 |
| 85 | MAF_26560356_Chip-Seq_TH2_Human | 0.93506312 |
| 86 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93284038 |
| 87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92132115 |
| 88 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.92131483 |
| 89 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.91500698 |
| 90 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.90608607 |
| 91 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.90132852 |
| 92 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88624640 |
| 93 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.88264120 |
| 94 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.85620815 |
| 95 | MYC_22102868_ChIP-Seq_BL_Human | 0.85501457 |
| 96 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.84235283 |
| 97 | GATA2_19941826_ChIP-Seq_K562_Human | 0.83721729 |
| 98 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.82340782 |
| 99 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81415820 |
| 100 | GATA3_26560356_Chip-Seq_TH2_Human | 0.80736284 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.63929711 |
| 2 | MP0009840_abnormal_foam_cell | 4.05854167 |
| 3 | MP0003303_peritoneal_inflammation | 3.73347631 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.58897388 |
| 5 | MP0006082_CNS_inflammation | 3.32193098 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.11379931 |
| 7 | MP0000604_amyloidosis | 3.09258758 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 3.06898114 |
| 9 | MP0003172_abnormal_lysosome_physiology | 3.00187224 |
| 10 | MP0003436_decreased_susceptibility_to | 2.93340203 |
| 11 | MP0000343_altered_response_to | 2.66335143 |
| 12 | MP0002419_abnormal_innate_immunity | 2.56250898 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.55777282 |
| 14 | MP0009785_altered_susceptibility_to | 2.54849945 |
| 15 | MP0004510_myositis | 2.54352936 |
| 16 | MP0003724_increased_susceptibility_to | 2.39270409 |
| 17 | MP0005451_abnormal_body_composition | 2.35099759 |
| 18 | MP0005671_abnormal_response_to | 2.27930898 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.18747972 |
| 20 | MP0009278_abnormal_bone_marrow | 2.16697866 |
| 21 | MP0001835_abnormal_antigen_presentation | 2.11923159 |
| 22 | MP0001853_heart_inflammation | 2.10980615 |
| 23 | MP0003075_altered_response_to | 2.08716932 |
| 24 | MP0009764_decreased_sensitivity_to | 2.07332428 |
| 25 | MP0005025_abnormal_response_to | 2.05128019 |
| 26 | MP0003329_amyloid_beta_deposits | 2.01609778 |
| 27 | MP0003300_gastrointestinal_ulcer | 2.01021447 |
| 28 | MP0005397_hematopoietic_system_phenotyp | 1.93351981 |
| 29 | MP0001545_abnormal_hematopoietic_system | 1.93351981 |
| 30 | MP0001790_abnormal_immune_system | 1.91486828 |
| 31 | MP0005387_immune_system_phenotype | 1.91486828 |
| 32 | MP0002998_abnormal_bone_remodeling | 1.90618177 |
| 33 | MP0002452_abnormal_antigen_presenting | 1.87134152 |
| 34 | MP0005167_abnormal_blood-brain_barrier | 1.83252921 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.81537333 |
| 36 | MP0002877_abnormal_melanocyte_morpholog | 1.72373187 |
| 37 | MP0002723_abnormal_immune_serum | 1.68662024 |
| 38 | MP0003195_calcinosis | 1.62337693 |
| 39 | MP0003656_abnormal_erythrocyte_physiolo | 1.62223088 |
| 40 | MP0001845_abnormal_inflammatory_respons | 1.59996832 |
| 41 | MP0003453_abnormal_keratinocyte_physiol | 1.59427656 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.58075154 |
| 43 | MP0003690_abnormal_glial_cell | 1.51084679 |
| 44 | MP0004947_skin_inflammation | 1.51036064 |
| 45 | MP0008004_abnormal_stomach_pH | 1.50852387 |
| 46 | MP0009333_abnormal_splenocyte_physiolog | 1.46846138 |
| 47 | MP0002405_respiratory_system_inflammati | 1.46046851 |
| 48 | MP0002420_abnormal_adaptive_immunity | 1.45609152 |
| 49 | MP0008469_abnormal_protein_level | 1.44184902 |
| 50 | MP0001819_abnormal_immune_cell | 1.44090213 |
| 51 | MP0005310_abnormal_salivary_gland | 1.43732130 |
| 52 | MP0001800_abnormal_humoral_immune | 1.40489303 |
| 53 | MP0006054_spinal_hemorrhage | 1.39334641 |
| 54 | MP0003448_altered_tumor_morphology | 1.35135813 |
| 55 | MP0000685_abnormal_immune_system | 1.34291944 |
| 56 | MP0005166_decreased_susceptibility_to | 1.30573185 |
| 57 | MP0002254_reproductive_system_inflammat | 1.27802682 |
| 58 | MP0000920_abnormal_myelination | 1.26206347 |
| 59 | MP0000858_altered_metastatic_potential | 1.25352474 |
| 60 | MP0002837_dystrophic_cardiac_calcinosis | 1.24203297 |
| 61 | MP0005365_abnormal_bile_salt | 1.15575433 |
| 62 | MP0010155_abnormal_intestine_physiology | 1.11436505 |
| 63 | MP0005164_abnormal_response_to | 1.03485947 |
| 64 | MP0008260_abnormal_autophagy | 1.02226368 |
| 65 | MP0002090_abnormal_vision | 0.97456969 |
| 66 | MP0000716_abnormal_immune_system | 0.97288580 |
| 67 | MP0005647_abnormal_sex_gland | 0.94540747 |
| 68 | MP0000371_diluted_coat_color | 0.91709179 |
| 69 | MP0001727_abnormal_embryo_implantation | 0.91115341 |
| 70 | MP0005165_increased_susceptibility_to | 0.89460126 |
| 71 | MP0005257_abnormal_intraocular_pressure | 0.88296740 |
| 72 | MP0004883_abnormal_blood_vessel | 0.88163541 |
| 73 | MP0009763_increased_sensitivity_to | 0.86849803 |
| 74 | MP0003795_abnormal_bone_structure | 0.85888761 |
| 75 | MP0003634_abnormal_glial_cell | 0.84205393 |
| 76 | MP0004808_abnormal_hematopoietic_stem | 0.82993266 |
| 77 | MP0010307_abnormal_tumor_latency | 0.81408474 |
| 78 | MP0003091_abnormal_cell_migration | 0.81079112 |
| 79 | MP0005390_skeleton_phenotype | 0.79373546 |
| 80 | MP0002332_abnormal_exercise_endurance | 0.78880462 |
| 81 | MP0002429_abnormal_blood_cell | 0.75464398 |
| 82 | MP0005410_abnormal_fertilization | 0.74467019 |
| 83 | MP0009765_abnormal_xenobiotic_induced | 0.73009951 |
| 84 | MP0008874_decreased_physiological_sensi | 0.70394504 |
| 85 | MP0002398_abnormal_bone_marrow | 0.70107136 |
| 86 | MP0005319_abnormal_enzyme/_coenzyme | 0.69796208 |
| 87 | MP0003828_pulmonary_edema | 0.69443464 |
| 88 | MP0000689_abnormal_spleen_morphology | 0.68411843 |
| 89 | MP0000609_abnormal_liver_physiology | 0.66287835 |
| 90 | MP0005023_abnormal_wound_healing | 0.64809081 |
| 91 | MP0000465_gastrointestinal_hemorrhage | 0.62609088 |
| 92 | MP0000249_abnormal_blood_vessel | 0.61342424 |
| 93 | MP0003950_abnormal_plasma_membrane | 0.61271206 |
| 94 | MP0004019_abnormal_vitamin_homeostasis | 0.60369698 |
| 95 | MP0003633_abnormal_nervous_system | 0.59244383 |
| 96 | MP0001542_abnormal_bone_strength | 0.59063430 |
| 97 | MP0002722_abnormal_immune_system | 0.57213385 |
| 98 | MP0002933_joint_inflammation | 0.56820154 |
| 99 | MP0005595_abnormal_vascular_smooth | 0.56747935 |
| 100 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.55636044 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 9.69993458 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 9.69993458 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 9.69993458 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 6.27104991 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 5.71453187 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.05991645 |
| 7 | Loss of speech (HP:0002371) | 4.96140061 |
| 8 | Dysostosis multiplex (HP:0000943) | 4.80242409 |
| 9 | Disinhibition (HP:0000734) | 4.74856364 |
| 10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.57817472 |
| 11 | Neurofibrillary tangles (HP:0002185) | 4.00255766 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 3.90777026 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 3.82136094 |
| 14 | Myocardial infarction (HP:0001658) | 3.76254142 |
| 15 | Mutism (HP:0002300) | 3.71495465 |
| 16 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.71293878 |
| 17 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.71293878 |
| 18 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.71293878 |
| 19 | Eczematoid dermatitis (HP:0000976) | 3.65308657 |
| 20 | Recurrent abscess formation (HP:0002722) | 3.65231054 |
| 21 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.54940360 |
| 22 | Mucopolysacchariduria (HP:0008155) | 3.54940360 |
| 23 | Autoimmune thrombocytopenia (HP:0001973) | 3.54138643 |
| 24 | Axonal loss (HP:0003447) | 3.51973036 |
| 25 | Nuclear cataract (HP:0100018) | 3.45324427 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.45109625 |
| 27 | Apathy (HP:0000741) | 3.44377031 |
| 28 | Diminished motivation (HP:0000745) | 3.42657589 |
| 29 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.32621054 |
| 30 | Metaphyseal irregularity (HP:0003025) | 3.25744632 |
| 31 | Mediastinal lymphadenopathy (HP:0100721) | 2.97570775 |
| 32 | Agnosia (HP:0010524) | 2.92882744 |
| 33 | Cerebral inclusion bodies (HP:0100314) | 2.89935753 |
| 34 | Upper motor neuron abnormality (HP:0002127) | 2.83927483 |
| 35 | Hepatosplenomegaly (HP:0001433) | 2.78773805 |
| 36 | Progressive neurologic deterioration (HP:0002344) | 2.78136574 |
| 37 | Stomatitis (HP:0010280) | 2.71850524 |
| 38 | Increased serum ferritin (HP:0003281) | 2.68458733 |
| 39 | Purpura (HP:0000979) | 2.66108246 |
| 40 | Neuronal loss in central nervous system (HP:0002529) | 2.62241068 |
| 41 | Prolonged neonatal jaundice (HP:0006579) | 2.58076361 |
| 42 | Inappropriate behavior (HP:0000719) | 2.56979781 |
| 43 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.52674278 |
| 44 | Petechiae (HP:0000967) | 2.48433881 |
| 45 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.45820874 |
| 46 | Chronic obstructive pulmonary disease (HP:0006510) | 2.40454298 |
| 47 | Obstructive lung disease (HP:0006536) | 2.40454298 |
| 48 | Personality changes (HP:0000751) | 2.38761273 |
| 49 | Dementia (HP:0000726) | 2.34963609 |
| 50 | Nausea (HP:0002018) | 2.33265282 |
| 51 | Xanthomatosis (HP:0000991) | 2.33198258 |
| 52 | Abnormality of the periventricular white matter (HP:0002518) | 2.28655738 |
| 53 | Protuberant abdomen (HP:0001538) | 2.28164942 |
| 54 | Poor head control (HP:0002421) | 2.27994319 |
| 55 | Asymmetric septal hypertrophy (HP:0001670) | 2.25090355 |
| 56 | Multiple enchondromatosis (HP:0005701) | 2.19960433 |
| 57 | Supranuclear gaze palsy (HP:0000605) | 2.19576021 |
| 58 | Interstitial pulmonary disease (HP:0006530) | 2.16621432 |
| 59 | Pathologic fracture (HP:0002756) | 2.16185405 |
| 60 | Hematochezia (HP:0002573) | 2.12564135 |
| 61 | Increased CSF protein (HP:0002922) | 2.10901539 |
| 62 | Bone pain (HP:0002653) | 2.10724216 |
| 63 | Amyloidosis (HP:0011034) | 2.09877445 |
| 64 | Glomerulonephritis (HP:0000099) | 2.09687221 |
| 65 | Retinal atrophy (HP:0001105) | 2.06962303 |
| 66 | Abnormality of iron homeostasis (HP:0011031) | 2.05435082 |
| 67 | Orchitis (HP:0100796) | 2.05341395 |
| 68 | Peripheral demyelination (HP:0011096) | 2.04896114 |
| 69 | J-shaped sella turcica (HP:0002680) | 2.04648794 |
| 70 | Generalized aminoaciduria (HP:0002909) | 2.04480018 |
| 71 | Retrobulbar optic neuritis (HP:0100654) | 2.03358457 |
| 72 | Optic neuritis (HP:0100653) | 2.03358457 |
| 73 | Cardiomegaly (HP:0001640) | 2.03068737 |
| 74 | Myositis (HP:0100614) | 2.01357151 |
| 75 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.97768028 |
| 76 | Vertebral compression fractures (HP:0002953) | 1.97051915 |
| 77 | Gingivitis (HP:0000230) | 1.95821039 |
| 78 | Recurrent skin infections (HP:0001581) | 1.88921357 |
| 79 | Basal ganglia calcification (HP:0002135) | 1.85459406 |
| 80 | Global brain atrophy (HP:0002283) | 1.82741126 |
| 81 | Malnutrition (HP:0004395) | 1.77680217 |
| 82 | Paralysis (HP:0003470) | 1.77509382 |
| 83 | Thoracic kyphosis (HP:0002942) | 1.77133781 |
| 84 | Polyneuropathy (HP:0001271) | 1.76309994 |
| 85 | Tetraparesis (HP:0002273) | 1.71731161 |
| 86 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.71644417 |
| 87 | Pulmonary infiltrates (HP:0002113) | 1.68301744 |
| 88 | Abnormal trabecular bone morphology (HP:0100671) | 1.68115899 |
| 89 | Abnormality of the lumbar spine (HP:0100712) | 1.67880261 |
| 90 | T lymphocytopenia (HP:0005403) | 1.67762965 |
| 91 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.66267229 |
| 92 | Neoplasm of head and neck (HP:0012288) | 1.66196318 |
| 93 | Esophageal neoplasm (HP:0100751) | 1.66196318 |
| 94 | Thin bony cortex (HP:0002753) | 1.65060368 |
| 95 | Hypophosphatemia (HP:0002148) | 1.64360006 |
| 96 | Conjunctival telangiectasia (HP:0000524) | 1.63779401 |
| 97 | Symptomatic seizures (HP:0011145) | 1.56648083 |
| 98 | Complement deficiency (HP:0004431) | 1.56559780 |
| 99 | Multiple lipomas (HP:0001012) | 1.56521064 |
| 100 | Splenomegaly (HP:0001744) | 1.56109696 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 6.89372811 |
| 2 | NME2 | 5.53621944 |
| 3 | BLK | 3.36402366 |
| 4 | GRK7 | 2.87132474 |
| 5 | TAOK2 | 2.84361242 |
| 6 | MAP3K14 | 2.60825291 |
| 7 | MAP3K11 | 2.41610681 |
| 8 | DDR2 | 2.36822499 |
| 9 | MAP2K3 | 2.18828124 |
| 10 | TBK1 | 2.07963271 |
| 11 | MAP3K3 | 2.01119323 |
| 12 | MATK | 1.99151784 |
| 13 | PIM2 | 1.93946090 |
| 14 | FGR | 1.91932895 |
| 15 | RIPK4 | 1.91007712 |
| 16 | ABL2 | 1.90827593 |
| 17 | ACVR1B | 1.84270485 |
| 18 | CSK | 1.83303841 |
| 19 | TAOK1 | 1.80178980 |
| 20 | TESK2 | 1.75446916 |
| 21 | MOS | 1.67766550 |
| 22 | TGFBR2 | 1.63785843 |
| 23 | IKBKB | 1.60226491 |
| 24 | CAMKK2 | 1.53958908 |
| 25 | IRAK4 | 1.51742407 |
| 26 | TYK2 | 1.46156308 |
| 27 | MAP3K13 | 1.41068487 |
| 28 | IKBKE | 1.30970809 |
| 29 | LIMK1 | 1.28416425 |
| 30 | PRPF4B | 1.28207556 |
| 31 | MAP3K1 | 1.26934274 |
| 32 | CAMK1D | 1.23392101 |
| 33 | PDK2 | 1.22918919 |
| 34 | ARAF | 1.21355934 |
| 35 | MAP3K5 | 1.18993591 |
| 36 | ZAP70 | 1.18805793 |
| 37 | ADRBK2 | 1.15771971 |
| 38 | CDC42BPA | 1.10979686 |
| 39 | TESK1 | 1.07546951 |
| 40 | MAP4K1 | 1.03896828 |
| 41 | MAP2K6 | 1.00892825 |
| 42 | NEK9 | 1.00453303 |
| 43 | BMPR2 | 0.95924418 |
| 44 | ERN1 | 0.94100848 |
| 45 | JAK3 | 0.94036693 |
| 46 | MARK3 | 0.93197958 |
| 47 | PAK4 | 0.87396631 |
| 48 | RIPK1 | 0.84338026 |
| 49 | SYK | 0.80793242 |
| 50 | LYN | 0.79312133 |
| 51 | CHUK | 0.79262977 |
| 52 | STK10 | 0.63528128 |
| 53 | TXK | 0.63365058 |
| 54 | ERBB4 | 0.63095718 |
| 55 | IRAK2 | 0.60747054 |
| 56 | PDPK1 | 0.53536749 |
| 57 | TTN | 0.51897123 |
| 58 | JAK2 | 0.50981105 |
| 59 | LCK | 0.50148514 |
| 60 | CAMK1G | 0.49147066 |
| 61 | PBK | 0.48176992 |
| 62 | CSF1R | 0.48155660 |
| 63 | MAP3K8 | 0.47386311 |
| 64 | HCK | 0.47264287 |
| 65 | BMX | 0.46411563 |
| 66 | PDK1 | 0.45208538 |
| 67 | PIM1 | 0.44991733 |
| 68 | MAPK4 | 0.44842885 |
| 69 | ABL1 | 0.43069665 |
| 70 | RPS6KC1 | 0.42680196 |
| 71 | RPS6KL1 | 0.42680196 |
| 72 | RPS6KA2 | 0.41280028 |
| 73 | CDK6 | 0.41226977 |
| 74 | PRKG2 | 0.40946947 |
| 75 | TAOK3 | 0.40928443 |
| 76 | JAK1 | 0.40109838 |
| 77 | MAP3K12 | 0.38739689 |
| 78 | MAPK12 | 0.38319056 |
| 79 | DYRK3 | 0.38165076 |
| 80 | BRAF | 0.36057699 |
| 81 | KIT | 0.35612969 |
| 82 | DAPK2 | 0.34813818 |
| 83 | TYRO3 | 0.32662666 |
| 84 | BTK | 0.31155871 |
| 85 | PDGFRA | 0.31151967 |
| 86 | KSR2 | 0.31116059 |
| 87 | RPS6KA6 | 0.30770646 |
| 88 | SCYL2 | 0.30086740 |
| 89 | STK24 | 0.28392960 |
| 90 | DAPK3 | 0.28066936 |
| 91 | CCNB1 | 0.27918971 |
| 92 | IRAK1 | 0.25689330 |
| 93 | EGFR | 0.24279607 |
| 94 | CSNK1G3 | 0.23811015 |
| 95 | CLK1 | 0.23497418 |
| 96 | GSK3A | 0.23281092 |
| 97 | CAMK2G | 0.22756011 |
| 98 | PAK1 | 0.22212893 |
| 99 | MAPK7 | 0.20919045 |
| 100 | ICK | 0.20673165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.44103197 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 4.13537258 |
| 3 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 3.27459537 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.27137433 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.92363632 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.52784961 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.49927940 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.47815692 |
| 9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.29320485 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.28212390 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 2.10511370 |
| 12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.05427795 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.00305110 |
| 14 | Phagosome_Homo sapiens_hsa04145 | 1.96300590 |
| 15 | Asthma_Homo sapiens_hsa05310 | 1.94242869 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.90961638 |
| 17 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.84977097 |
| 18 | Allograft rejection_Homo sapiens_hsa05330 | 1.83192603 |
| 19 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.80994098 |
| 20 | Pertussis_Homo sapiens_hsa05133 | 1.79219880 |
| 21 | Legionellosis_Homo sapiens_hsa05134 | 1.76640064 |
| 22 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.71721996 |
| 23 | Salmonella infection_Homo sapiens_hsa05132 | 1.71659213 |
| 24 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.70635712 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.70468952 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.59672943 |
| 27 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.50581479 |
| 28 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.49706990 |
| 29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.44801363 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39495788 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.36400541 |
| 32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.35878193 |
| 33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.34193810 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.33541311 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.25095581 |
| 36 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.21209357 |
| 37 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.19791978 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.17644806 |
| 39 | Galactose metabolism_Homo sapiens_hsa00052 | 1.13696776 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.12381710 |
| 41 | Bladder cancer_Homo sapiens_hsa05219 | 1.10067182 |
| 42 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.07023899 |
| 43 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.06836468 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.02374799 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 1.01890657 |
| 46 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.99333936 |
| 47 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.98574693 |
| 48 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.98521320 |
| 49 | Viral myocarditis_Homo sapiens_hsa05416 | 0.89198926 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.88324654 |
| 51 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.87785785 |
| 52 | Prion diseases_Homo sapiens_hsa05020 | 0.87699385 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.87396461 |
| 54 | Apoptosis_Homo sapiens_hsa04210 | 0.82013437 |
| 55 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.81663992 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 0.80760743 |
| 57 | Mineral absorption_Homo sapiens_hsa04978 | 0.78767195 |
| 58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.73739857 |
| 59 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.71884377 |
| 60 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.71755358 |
| 61 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.69721699 |
| 62 | Hepatitis B_Homo sapiens_hsa05161 | 0.67729160 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.67178710 |
| 64 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66721772 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66378822 |
| 66 | Amoebiasis_Homo sapiens_hsa05146 | 0.65079695 |
| 67 | Measles_Homo sapiens_hsa05162 | 0.63698959 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61796437 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61154096 |
| 70 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61097502 |
| 71 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.60470279 |
| 72 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.59779935 |
| 73 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.58444866 |
| 74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53939925 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50488790 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50473071 |
| 77 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.46349517 |
| 78 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44310327 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40815187 |
| 80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40579185 |
| 81 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.39927396 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38471834 |
| 83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37022883 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.30495832 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.26871701 |
| 86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.25893578 |
| 87 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.23820444 |
| 88 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.21795212 |
| 89 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.20381546 |
| 90 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.19744281 |
| 91 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.19002448 |
| 92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.18689279 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.16865117 |
| 94 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.14115893 |
| 95 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.14111462 |
| 96 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.13477606 |
| 97 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.13100995 |
| 98 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.12714863 |
| 99 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.12171358 |
| 100 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.11250835 |

